DelveInsight Business Research, LLP: Radiotherapy-Induced Oral Mucositis Market Set for Strong Growth Through 2036, Driven by Emerging Therapies and Rising Cancer Burden
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Thu, 20 August 2026
What it is about
Sharad Chandra VinayakEli LillyEpicentrx RrxProthex PharmaShruti ThakurAurora BioscienceMureva LumitexSoligenix DusquetideMarket ResearchNovartisGalera Therapeutics IncEnzychem Lifesciences CorporationActinium PharmaceuticalsAmgenNational Cancer InstituteTelix PharmaceuticalsUnited StatesRadiation Therapy Oncology GroupPfizerUconn Health
Who published it, and when
How it spread - 1 original report
Thu, 20 August 2026
1 report- finanznachrichten.de16:36first to report
The radiotherapy-induced oral mucositis market is expected to witness significant growth due to the increasing incidence of head and neck cancers and the expanding use of radiotherapy as a standard